June 11, 2026 9:22 am

Author: Ben Rogers

Founder, IBD Movement | Living with Crohn's since 2002

Revolutionary TL1A Therapies Bring New Hope to IBD Patients

Multiple pharmaceutical giants are racing to develop TL1A binder therapies that could revolutionize IBD treatment by targeting inflammation in a completely new way. Early clinical trial results show promising remission and healing rates, offering genuine hope for patients who need better treatment options.

You Missed

Probiotics and IBD: What 20+ Years of Living with Crohn's Taught Me

Probiotics and IBD: What 20+ Years of Living with Crohn’s Taught Me

May 26, 2026
Week of May 18-24, 2026: 4 IBD research stories worth your attention

Week of May 18-24, 2026: 4 IBD research stories worth your attention

May 26, 2026
Week of May 11-17, 2026: Seven IBD research stories worth your attention

Week of May 11-17, 2026: Seven IBD research stories worth your attention

May 17, 2026